Introduction:
The pharmaceutical industry in India has been steadily growing over the past few years, with a significant focus on the production of generic over-the-counter (OTC) medicines. The country has become a key player in the global pharmaceutical market, with a production volume of over 20% of the world’s generics. In this report, we will highlight the top 10 generic OTC medicine manufacturers in India based on their market share and production volume.
Top 10 Generic Over-the-Counter (OTC) Medicine Manufacturers in India:
1. Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. is one of the largest pharmaceutical companies in India, with a market share of over 10% in the generic OTC medicine segment. The company has a strong presence in both domestic and international markets, with a production volume of over 1 billion units annually.
2. Cipla Ltd.
Cipla Ltd. is another leading player in the Indian pharmaceutical industry, specializing in generic OTC medicines. The company holds a market share of around 8% and exports its products to over 100 countries worldwide. Cipla’s production volume exceeds 800 million units per year.
3. Lupin Limited
Lupin Limited is known for its high-quality generic OTC medicines and holds a market share of approximately 6% in India. The company has a strong presence in the US market and exports to over 50 countries globally. Lupin’s production volume is estimated to be around 700 million units annually.
4. Dr. Reddy’s Laboratories Ltd.
Dr. Reddy’s Laboratories Ltd. is a renowned pharmaceutical company in India, with a market share of 5% in the generic OTC medicine segment. The company has a diverse product portfolio and exports its products to over 25 countries. Dr. Reddy’s production volume is around 600 million units per year.
5. Zydus Cadila
Zydus Cadila is a leading player in the Indian pharmaceutical market, with a market share of 4% in the generic OTC medicine segment. The company has a strong focus on research and development and exports its products to over 50 countries. Zydus Cadila’s production volume exceeds 500 million units annually.
6. Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd. is a key player in the Indian pharmaceutical industry, with a market share of 3% in the generic OTC medicine segment. The company has a strong presence in the domestic market and exports its products to over 40 countries worldwide. Torrent Pharmaceuticals’ production volume is estimated to be around 400 million units per year.
7. Alembic Pharmaceuticals Ltd.
Alembic Pharmaceuticals Ltd. is known for its innovative generic OTC medicines and holds a market share of approximately 2% in India. The company has a growing presence in international markets and exports to over 30 countries. Alembic Pharmaceuticals’ production volume is around 300 million units annually.
8. Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd. is a well-established player in the Indian pharmaceutical industry, with a market share of 2% in the generic OTC medicine segment. The company has a strong focus on research and development and exports its products to over 50 countries globally. Glenmark Pharmaceuticals’ production volume exceeds 250 million units per year.
9. Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. is a leading pharmaceutical company in India, with a market share of 1% in the generic OTC medicine segment. The company has a diverse product portfolio and exports its products to over 100 countries worldwide. Aurobindo Pharma’s production volume is estimated to be around 200 million units annually.
10. Mankind Pharma Ltd.
Mankind Pharma Ltd. is a fast-growing player in the Indian pharmaceutical market, with a market share of 1% in the generic OTC medicine segment. The company has a strong presence in the domestic market and exports its products to over 25 countries globally. Mankind Pharma’s production volume is around 150 million units per year.
Insights:
The Indian pharmaceutical industry is expected to continue its growth trajectory in the coming years, driven by the increasing demand for generic OTC medicines both domestically and internationally. With a focus on research and development, innovation, and quality, Indian pharmaceutical companies are well-positioned to capitalize on this growing market. According to industry reports, the generic OTC medicine market in India is projected to reach $5 billion by 2025, with a compound annual growth rate of 8%. This presents significant opportunities for the top manufacturers to expand their market share and solidify their position in the industry.
Related Analysis: View Previous Industry Report
